Striae gravidarum treatment : evaluating non-ablating fractional laser (NAFL) efficacy and safety
BACKGROUND: Striae gravidarum (SG) is a common pregnancy-related dermatologic problem, for which finding an effective treatment remains a challenge.
AIM: To evaluate the safety and efficacy of 1540 nm non-ablative fractional laser (Star lux 500) in the treatment of SG in Iranian women and peruse the relationship between clinical improvement rate and patient characteristics as well as clinical features of striae.
METHOD: A prospective before-after study was conducted on 50 patients with SG who received three monthly sessions of 1540 nm non-ablative fractional laser and were followed for 2 months after the last treatment session. Clinical changes were measured using both provider-rated outcome through before/after pictures represented by final clinical score (from 0 to 5) and patient-reported outcome (patient global assessment or PGA).
RESULTS: Over the course of the study both final clinical score and PGA increased significantly from week 4 to week 20 (P value: <0.001 and 0.048, respectively). Only modest adverse effects including erythema, edema and hyperpigmentation were noted.
CONCLUSION: In conclusion, patients with SG of different type (rubra/alba) or maturity may somehow benefit from treatment with NAFL experiencing minimal transient side effects.Therefore, NAFL may be considered a safe and partially effective treatment option for stretch mark of patients with SG.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
|---|---|
| Enthalten in: |
Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology - 25(2023), 1-4 vom: 19. Mai, Seite 20-24 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nourmohammadpour, Pedram [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
1540 nm non-ablative fractional laser |
|---|
| Anmerkungen: |
Date Completed 04.09.2023 Date Revised 04.09.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/14764172.2023.2221837 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358108845 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358108845 | ||
| 003 | DE-627 | ||
| 005 | 20231226074038.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/14764172.2023.2221837 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1193.xml |
| 035 | |a (DE-627)NLM358108845 | ||
| 035 | |a (NLM)37309187 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nourmohammadpour, Pedram |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Striae gravidarum treatment |b evaluating non-ablating fractional laser (NAFL) efficacy and safety |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.09.2023 | ||
| 500 | |a Date Revised 04.09.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Striae gravidarum (SG) is a common pregnancy-related dermatologic problem, for which finding an effective treatment remains a challenge | ||
| 520 | |a AIM: To evaluate the safety and efficacy of 1540 nm non-ablative fractional laser (Star lux 500) in the treatment of SG in Iranian women and peruse the relationship between clinical improvement rate and patient characteristics as well as clinical features of striae | ||
| 520 | |a METHOD: A prospective before-after study was conducted on 50 patients with SG who received three monthly sessions of 1540 nm non-ablative fractional laser and were followed for 2 months after the last treatment session. Clinical changes were measured using both provider-rated outcome through before/after pictures represented by final clinical score (from 0 to 5) and patient-reported outcome (patient global assessment or PGA) | ||
| 520 | |a RESULTS: Over the course of the study both final clinical score and PGA increased significantly from week 4 to week 20 (P value: <0.001 and 0.048, respectively). Only modest adverse effects including erythema, edema and hyperpigmentation were noted | ||
| 520 | |a CONCLUSION: In conclusion, patients with SG of different type (rubra/alba) or maturity may somehow benefit from treatment with NAFL experiencing minimal transient side effects.Therefore, NAFL may be considered a safe and partially effective treatment option for stretch mark of patients with SG | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a 1540 nm non-ablative fractional laser | |
| 650 | 4 | |a Striea distensae | |
| 650 | 4 | |a laser | |
| 650 | 4 | |a pregnancy | |
| 650 | 4 | |a starlux | |
| 650 | 4 | |a striae gravidarum | |
| 700 | 1 | |a Ehsani, Amir Houshang |e verfasserin |4 aut | |
| 700 | 1 | |a Hatami, Parvaneh |e verfasserin |4 aut | |
| 700 | 1 | |a Aref, Saeed |e verfasserin |4 aut | |
| 700 | 1 | |a Aryanian, Zeinab |e verfasserin |4 aut | |
| 700 | 1 | |a Goodarzi, Azadeh |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology |d 2001 |g 25(2023), 1-4 vom: 19. Mai, Seite 20-24 |w (DE-627)NLM11882600X |x 1476-4180 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2023 |g number:1-4 |g day:19 |g month:05 |g pages:20-24 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/14764172.2023.2221837 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2023 |e 1-4 |b 19 |c 05 |h 20-24 | ||